New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group

January 28, 2026
Share on

AUTHORS

Maria Della Volpe-Waizel, Ghislaine L Traber, Peter Maloca, Martin Zinkernagel, Ursula Schmidt-Erfurth, Gary Rubin, Botond Roska, Tilman Otto, Richard G Weleber, Hendrik P N Scholl

Ophthalmic Res. 2020;63(2):77-87. doi: 10.1159/000501887. Epub 2019 Jul 26.

ABSTRACT

Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop’s presentations in the context of published literature.

PMID:31352462 | DOI:10.1159/000501887

View in PubMed